⌘K

Login Start Free

Home/Filings/4/0001144204-19-018898

4//SEC Filing

PRZYBYL ARTHUR 4

Accession 0001144204-19-018898

CIK 0001023024other

View on SEC.gov Company Profile

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 4:41 PM ET

Size

6.5 KB

Accession

0001144204-19-018898

Insider Transaction Report

Form 4

Period: 2019-04-06

ANI PHARMACEUTICALS INCANIP

DirectorPresident and CEO

Transactions

Tax Payment
Common Stock
2019-04-06$70.50/sh−3,282$231,381→ 236,396 total
Tax Payment
Common Stock
2019-04-07$70.50/sh−2,115$149,108→ 234,281 total

Footnotes (2)

[F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,275 shares of restricted stock, which was previously reported.
[F2]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,688 shares of restricted stock, which was previously reported.

Documents

1 file

4
tv518451_form4.xmlPrimary
FORM 4

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1

filerCIK 0001268135

Filing Metadata

Form type: 4
Filed: Apr 8, 8:00 PM ET
Accepted: Apr 9, 4:41 PM ET
Size: 6.5 KB

View on SEC.gov